GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-1,757 Cr | ₹1,208 Cr | ₹-1,003 Cr | ₹-1,524 Cr | ₹-766 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLAND PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-1,757 Cr |
Mar2023 | ₹1,208 Cr |
Mar2022 | ₹-1,003 Cr |
Mar2021 | ₹-1,524 Cr |
Mar2020 | ₹-766 Cr |
How is Cash Flow from Investing Activities of GLAND PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,757 Cr | Negative | |
Mar2023 | ₹1,208 Cr | Positive | |
Mar2022 | ₹-1,003 Cr | Negative | |
Mar2021 | ₹-1,524 Cr | Negative | |
Mar2020 | ₹-766 Cr | - |
Compare Cash Flow from Investing Activities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹30,881.0 Cr | 2.3% | 15% | 3.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 2.3% |
15% |
3.4% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses